Psychological Health/Traumatic Brain Injury, Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award | W81XWH 18 PHTBIRP LIMBIC

Frequently Asked Questions (FAQs)

What is the LIMBIC Award?

The Psychological Health/Traumatic Brain Injury, Long-Term Impact of Military-Relevant Brain Injury Consortium (LIMBIC) Award is a Department of Defense (DoD) research funding opportunity under the Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP). It was first introduced in FY18 and is intended to support a single, coordinated research Consortium focused on the long-term effects of mild traumatic brain injury (mTBI), often described as concussion, in people with military-relevant exposures and experiences.

What is the main purpose of this funding opportunity?

The core purpose is to strengthen what is known about the long-term impacts of military-relevant mTBI by supporting one large, longitudinal study (tracking individuals over time) and related sub-studies. The DoD emphasizes that the resulting knowledge should be usable to improve clinical pathways and decision-making for TBI care.

What type of brain injury is this opportunity focused on?

This opportunity focuses on mild traumatic brain injury (mTBI), commonly referred to as concussion, particularly in populations with military-relevant exposures and experiences.

Who are the priority populations for the research?

The description places particular emphasis on Service members and Veterans, and more broadly on individuals with military-relevant exposures and experiences who are appropriate for a longitudinal mTBI cohort.

What makes the LIMBIC Award different from funding multiple separate projects?

Rather than funding many smaller, independent projects, the LIMBIC Award is designed to stand up a single coordinated Consortium. That Consortium is expected to run one major longitudinal "backbone" study and enable additional sub-studies within a unified cohort and shared infrastructure.

What does "longitudinal study" mean in the context of this award?

A longitudinal study follows the same individuals over time. For LIMBIC, this design is intended to help researchers understand how mTBI evolves, what factors predict recovery versus persistent problems, and how outcomes interact with other issues common in military populations.

What kinds of outcomes or symptoms is the research expected to consider?

The opportunity notes that mTBI can involve a wide range of outcomes, including cognitive changes, headaches, sleep problems, mood symptoms, and occupational impacts. A major goal is to clarify which problems are most strongly linked to mTBI itself versus those driven by co-occurring conditions or influenced by deployment-related exposures or other risk factors.

What is the expected practical impact on healthcare and clinical care?

The award is framed around practical impact on care, with expected payoffs including knowledge that can improve clinical pathways for TBI. This includes better acute care right after injury and stronger systems of support for chronic or lingering symptoms. The intent is to produce evidence that helps clinicians and health systems make better decisions about screening, monitoring, referral, treatment planning, and long-term follow-up.

Is the LIMBIC Award meant to support purely descriptive research?

No. The description emphasizes that the program is not only seeking descriptive data, but evidence that can be used to improve clinical pathways and decision-making for TBI care across acute and long-term management.

How does this opportunity relate to broader federal strategies like NRAP?

The opportunity explicitly ties into the National Research Action Plan (NRAP), developed in response to Executive Order 13625, which focused on improving access to mental health services for Veterans, Service members, and military families. NRAP encourages coordinated, cross-agency work to improve diagnostics and therapies for PTSD, TBI, suicide, and related conditions, and highlights longitudinal cohorts as a key approach.

Is there collaboration between DoD and VA connected to this award?

Yes. The description indicates ongoing collaboration between the DoD and the Department of Veterans Affairs Office of Research and Development (VA ORD). The research questions and data are intended to be relevant across the transition from active duty to Veteran status and useful to both defense and veteran health systems.

Why does the opportunity mention blast exposure and neurodegenerative outcomes?

The funding description references concerns about blast exposures and possible later-life neurodegenerative outcomes, including recommendations from a 2015 DoD Blast Injury Research Program Coordinating Office international meeting. That meeting called for longitudinal studies to evaluate potential links between blast-related TBI and chronic traumatic encephalopathy (CTE).

Does the LIMBIC Award focus specifically on chronic traumatic encephalopathy (CTE)?

The opportunity references CTE in the context of concerns and recommendations motivating longitudinal research on blast-related TBI. It presents the Consortium approach as a way to evaluate potential links and support sustained, streamlined work in this space, alongside other long-term outcome questions within the unified cohort.

How many awards were expected to be made?

The record indicates that one award was expected (ExpectedAwards: 1), consistent with the intent to fund a single Consortium.

What funding mechanism is used (grant vs cooperative agreement)?

This is described as a discretionary funding opportunity using a cooperative agreement. In general, that implies substantial government involvement in shaping or overseeing aspects of the project compared with a standard grant.

Who is the sponsoring agency and who administers the opportunity?

The sponsoring agency is the Department of Defense, Department of the Army, with administration through USAMRAA.

What is the CFDA number and category listed for this opportunity?

The opportunity is listed under CFDA 12.420 and categorized under science and technology/research and development.

What is the funding opportunity number?

The funding opportunity number is W81XWH-18-PHTBIRP-LIMBIC.

Who is eligible to apply?

Eligibility is listed as unrestricted (open to any type of entity), subject to any additional eligibility language that may exist in the full announcement.

When was the opportunity posted and when did it close?

The record lists a posting date of August 21, 2018, with an original application closing date of January 7, 2019.

What is the award ceiling (maximum funding amount)?

The award ceiling is listed as 0 in the record, which typically indicates that a maximum amount was not specified in that particular data field. The specific maximum (if any) would need to be confirmed in the full program announcement.

What would an applicant be proposing to do under this opportunity?

An applicant would be proposing to lead (or assemble) a multi-institutional Consortium capable of enrolling and following a large longitudinal cohort that includes Service members, Veterans, and other relevant populations. The Consortium would collect consistent data over time and support sub-studies that address high-priority questions about long-term outcomes after military-relevant mTBI within a unified cohort and shared infrastructure.

What is meant by "sub-studies" in this Consortium model?

Sub-studies are additional focused studies that fit within the scope of the program announcement and are conducted within the Consortium structure. They are intended to address specific high-priority questions while leveraging the shared cohort, data collection, and infrastructure of the overall longitudinal study.

What is the intended end goal of the LIMBIC Consortium?

The end goal is a clearer, evidence-backed picture of long-term trajectories and mechanisms after military-relevant mTBI that can directly inform better TBI care from the point of injury through long-term management, including chronic-care supports for individuals with persistent symptoms.